DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer
American Journal of Clinical and Experimental Immunology · 2025
DOI: 10.62347/bthg8733 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2025. Verfasst von Jieyu Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou 215006, Jiangsu, China. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou 215006, Jiangsu, China.
- Department of Nuclear Accident Medical Emergency, The Second Affiliated Hospital of Soochow University Suzhou 215004, Jiangsu, China.
- Medical College of Soochow University Suzhou 215123, Jiangsu, China.
Zitieren
APA
Jin, J., Feng, J., Zhou, T., Cao, J., Feng, B., Tang, Q., Zhang, S., Qiu, J., & Liang, Y. (2025). DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer. American Journal of Clinical and Experimental Immunology. https://doi.org/10.62347/bthg8733
Vancouver
Jin J, Feng J, Zhou T, Cao J, Feng B, Tang Q, et al. DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer. American Journal of Clinical and Experimental Immunology. 2025. doi:10.62347/bthg8733
BibTeX
@article{Jin2025,
author = {Jin, Jieyu and Feng, Junchao and Zhou, Tong and Cao, Jun and Feng, Bin and Tang, Qingqin and Zhang, Sheng and Qiu, Jun and Liang, Yuting},
title = {DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2025},
doi = {10.62347/bthg8733}
}
EUVIMED